Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
Artica Therapeutics has raised $12.7M in total funding. The most recent round was Seed. The last funding was announced in November 2023.
Artica Therapeutics's investors include InnovationQuarter, BioGeneration Ventures, Seroba Life Sciences, Thuja Capital.
Artica Therapeutics is headquartered in Leiden, The Netherlands.
Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
Artica Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Artica Therapeutics — Funding & Investors." VCBacked, November 2, 2023, https://www.vcbacked.co/company/artica-therapeutics. Accessed September 30, 2026.
VCBacked. (2023). Artica Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/artica-therapeutics
{{cite web |title=Artica Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/artica-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated